Works by Gustafson, D. L.

Results: 12

The Flint Animal Cancer Center ( FACC) Canine Tumour Cell Line Panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.

Published in:

Veterinary & Comparative Oncology, 2017, v. 15, n. 2, p. 481, doi. 10.1111/vco.12192

By:

Fowles, J. S.;
Dailey, D. D.;
Gustafson, D. L.;
Thamm, D. H.;
Duval, D. L.

Publication type:

Article

Comparative analysis of MAPK and PI3K/AKT pathway activation and inhibition in human and canine melanoma.

Published in:

Veterinary & Comparative Oncology, 2015, v. 13, n. 3, p. 288, doi. 10.1111/vco.12044

By:

Fowles, J. S.;
Denton, C. L.;
Gustafson, D. L.

Publication type:

Article

Development of a limited-sampling model for prediction of doxorubicin exposure in dogs.

Published in:

Veterinary & Comparative Oncology, 2014, v. 12, n. 2, p. 114, doi. 10.1111/j.1476-5829.2012.00340.x

By:

Wittenburg, L. A.;
Thamm, D. H.;
Gustafson, D. L.

Publication type:

Article

Induction of VEGF by tepoxalin does not lead to increased tumour growth in a canine osteosarcoma xenograft.

Published in:

Veterinary & Comparative Oncology, 2011, v. 9, n. 2, p. 118, doi. 10.1111/j.1476-5829.2010.00240.x

By:

Sottnik, J. L.;
Hansen, R. J.;
Gustafson, D. L.;
Dow, S. W.;
Thamm, D. H.

Publication type:

Article

Pharmacokinetic Modeling of Doxorubicin Pharmacokinetics in Dogs Deficient in ABCB1 Drug Transporters.

Published in:

Journal of Veterinary Internal Medicine, 2010, v. 24, n. 3, p. 579, doi. 10.1111/j.1939-1676.2010.0496.x

By:

Gustafson, D. L.;
Thamm, D. H.

Publication type:

Article

Limited sampling pharmacokinetics of subcutaneous ondansetron in healthy geriatric cats, cats with chronic kidney disease, and cats with liver disease.

Published in:

Journal of Veterinary Pharmacology & Therapeutics, 2016, v. 39, n. 4, p. 350, doi. 10.1111/jvp.12286

By:

Fitzpatrick, R. L.;
Wittenburg, L. A.;
Hansen, R. J.;
Gustafson, D. L.;
Quimby, J. M.

Publication type:

Article

Single- and multiple dose pharmacokinetics and multiple dose pharmacodynamics of oral ABT-116 (a TRPV1 antagonist) in dogs.

Published in:

Journal of Veterinary Pharmacology & Therapeutics, 2015, v. 38, n. 4, p. 336, doi. 10.1111/jvp.12180

By:

Niyom, S.;
Mama, K. R.;
Gustafson, D. L.;
Rezende, M. L.

Publication type:

Article

Oral, subcutaneous, and intravenous pharmacokinetics of ondansetron in healthy cats.

Published in:

Journal of Veterinary Pharmacology & Therapeutics, 2014, v. 37, n. 4, p. 348, doi. 10.1111/jvp.12094

By:

Quimby, J. M.;
Lake, R. C.;
Hansen, R. J.;
Lunghofer, P. J.;
Gustafson, D. L.

Publication type:

Article

Studies on the pharmacokinetics and pharmacodynamics of mirtazapine in healthy young cats.

Published in:

Journal of Veterinary Pharmacology & Therapeutics, 2011, v. 34, n. 4, p. 388, doi. 10.1111/j.1365-2885.2010.01244.x

By:

Quimby, J. M.;
Gustafson, D. L.;
Samber, B. J.;
Lunn, K. F.

Publication type:

Article

Clinical efficacy, safety and pharmacokinetics of a novel long‐acting intramuscular omeprazole in performance horses with gastric ulcers.

Published in:

Equine Veterinary Education, 2022, v. 34, n. 11, p. 573, doi. 10.1111/eve.13546

By:

Lehman, M. L.;
Bass, L.;
Gustafson, D. L.;
Rao, S.;
O'Fallon, E. S.

Publication type:

Article

Expression of Phosphorylated KIT in Canine Mast Cell Tumor.

Published in:

Veterinary Pathology, 2017, v. 54, n. 3, p. 387, doi. 10.1177/0300985816688943

By:

Halsey, C. H. C.;
Thamm, D. H.;
Weishaar, K. M.;
Burton, J. H.;
Charles, J. B.;
Gustafson, D. L.;
Avery, A. C.;
Ehrhart, E. J.

Publication type:

Article

Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib.

Published in:

2010

By:

Flaig, T. W.;
Costa, L. J.;
Gustafson, D. L.;
Breaker, K.;
Schultz, M. K.;
Crighton, F.;
Kim, F. J.;
Drabkin, H.

Publication type:

journal article